Syndicated Research Studies

Prostate Cancer Diagnostics Market Growth & Trends The global prostate cancer diagnostics market size is expected to reach USD 13.16 billion by 2030, expanding at a CAGR of 6.4% from 2024 to 2030,according to a new report by Grand View Research, Inc. Supportive government initiatives, increasing disease prevalence across the globe, and a rise in the prevalence of prostate cancer coupled with technological advancements in confirmatory diagnostic tests are the major drivers for this market. A rise in favorable government initiatives to enhance research associated with a focus on effective diagnosis and treatment is expected to boost market growth during the forecast period. For instance, the National Cancer Institute initiated the study titled ‘Research on Prostate Cancer in Men of African Ancestry: Defining the Roles of Genetics, Tumor Markers, and Social Stress’ (RESPOND). This study is the largest collaboration to research the non-biological and biologi...

Prostate Cancer Diagnostics Industry Overview The global  prostate cancer diagnostics market  size is expected to reach USD 7.65 billion by 2027, registering a CAGR of 13.2% during the forecast period, according to a new report by Grand View Research, Inc. Major drivers include increasing government initiatives, high prevalence of prostate cancer, and technological advancements in confirmatory diagnostic tests. Prostate Cancer Diagnostics Market Segmentation Grand View Research has segmented the global prostate cancer diagnostics market report on the basis of test type and region: Based on the Test Type Insights, the market is segmented into Preliminary Tests and Confirmatory Tests. Preliminary test segment is expected to hold the largest market share over the forecast period, owing to a rise in prevalence of prostate cancer. According to the American Institute for Cancer Research, easy availability of PSA screening has facilitated early diagnosis and treatment, increa...